News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genizon BioSciences Inc. Licenses Crohn's Disease GeneMap To Genentech, Inc. (DNA); Results Of Whole Genome Association Study To Be Used To Support Development Of New Therapeutics And Diagnostics


8/8/2006 11:48:30 AM

MONTREAL, August 8 /CNW/ - Genizon BioSciences today announced a license and collaboration agreement with Genentech, Inc. (NYSE:DNA) of South San Francisco, Calif. Genizon grants Genentech an exclusive license to Genizon's GeneMap of disease-associated genes generated from a whole genome association study of Crohn's disease patients from the Quebec Founder Population.

Read at Canada NewsWire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES